Scientific Team

Jorge Gomez-Galeno, Ph.D., Scientist.

Dr. Gomez-Galeno is a bioorganic/medicinal chemist with extensive experience in preparation and evaluation of pharmacologically active compounds. Prior to joining ChemRegen, he was Director of Chemistry at Advantageous Systems, LLC, where he designed and synthesized nanomaterials for the removal of micro contaminants from water and for use in diagnostic systems.Before that, at Metabasis Therapeutics, he lead a team that identified a candidate for the treatment of diabetes that entered Phase 2 clinical studies in 2016. In addition he also led a team that identified a novel, potent and selective AMPK activator that was licensed to Merck.